Elisaf M - Search Results

1

Recommendations for lipid modification in patients with ischemic stroke or transient ischemic attack: A clinical guide by the Hellenic Stroke Organization and the Hellenic Atherosclerosis Society.

Sagris D, Ntaios G, Georgiopoulos G, Kakaletsis N, Elisaf M, Katsiki N, Korompoki E, Kypreos KE, Boutari C, Bilianou H, Makaritsis K, Nomikos T, Papavasileiou V, Pitsavos C, Plomaritoglou A, Spengos K, Tziomalos K, Tselepis A, Vemmos K, Liberopoulos E, Milionis H. Sagris D, et al. Among authors: elisaf m. Int J Stroke. 2021 Aug;16(6):738-750. doi: 10.1177/1747493020971970. Epub 2020 Nov 17. Int J Stroke. 2021. PMID: 33202196

2

Atorvastatin preferentially reduces LDL-associated platelet-activating factor acetylhydrolase activity in dyslipidemias of type IIA and type IIB.

Tsimihodimos V, Karabina SA, Tambaki AP, Bairaktari E, Goudevenos JA, Chapman MJ, Elisaf M, Tselepis AD. Tsimihodimos V, et al. Among authors: elisaf m. Arterioscler Thromb Vasc Biol. 2002 Feb 1;22(2):306-11. doi: 10.1161/hq0202.102918. Arterioscler Thromb Vasc Biol. 2002. PMID: 11834533 Clinical Trial.

3

Altered distribution of platelet-activating factor- acetylhydrolase activity between LDL and HDL as a function of the severity of hypercholesterolemia.

Tsimihodimos V, Karabina SA, Tambaki AP, Bairaktari E, Miltiadous G, Goudevenos JA, Cariolou MA, Chapman MJ, Tselepis AD, Elisaf M. Tsimihodimos V, et al. Among authors: elisaf m. J Lipid Res. 2002 Feb;43(2):256-63. J Lipid Res. 2002. PMID: 11861667 Free article.

4

Are the effects of tamoxifen on the serum lipid profile modified by apolipoprotein E phenotypes?

Liberopoulos E, Karabina SA, Tselepis A, Bairaktari E, Nicolaides C, Pavlidis N, Elisaf M. Liberopoulos E, et al. Among authors: elisaf m. Oncology. 2002;62(2):115-20. doi: 10.1159/000048256. Oncology. 2002. PMID: 11914596

5

Hypomagnesemia and concurrent acid-base and electrolyte abnormalities in patients with congestive heart failure.

Milionis HJ, Alexandrides GE, Liberopoulos EN, Bairaktari ET, Goudevenos J, Elisaf MS. Milionis HJ, et al. Eur J Heart Fail. 2002 Mar;4(2):167-73. doi: 10.1016/s1388-9842(01)00234-3. Eur J Heart Fail. 2002. PMID: 11959045 Free article.

6

The hyponatremic patient: a systematic approach to laboratory diagnosis.

Milionis HJ, Liamis GL, Elisaf MS. Milionis HJ, et al. CMAJ. 2002 Apr 16;166(8):1056-62. CMAJ. 2002. PMID: 12002984 Free PMC article. Review.

7

Hypokalaemia in alcoholic patients.

Elisaf M, Liberopoulos E, Bairaktari E, Siamopoulos K. Elisaf M, et al. Drug Alcohol Rev. 2002 Mar;21(1):73-6. doi: 10.1080/09595230220119282a. Drug Alcohol Rev. 2002. PMID: 12189007

8

Severe hyperkalaemia in association with diabetic ketoacidosis in a patient presenting with severe generalized muscle weakness.

Milionis HJ, Dimos G, Elisaf MS. Milionis HJ, et al. Nephrol Dial Transplant. 2003 Jan;18(1):198-200. doi: 10.1093/ndt/18.1.198. Nephrol Dial Transplant. 2003. PMID: 12480984 No abstract available.

9

Acid-base and electrolyte disturbances in patients with hypercalcemia.

Milionis HJ, Rizos E, Liamis G, Nikas S, Siamopoulos KC, Elisaf MS. Milionis HJ, et al. South Med J. 2002 Nov;95(11):1280-7. South Med J. 2002. PMID: 12539994

10

Fenofibrate induces HDL-associated PAF-AH but attenuates enzyme activity associated with apoB-containing lipoproteins.

Tsimihodimos V, Kakafika A, Tambaki AP, Bairaktari E, Chapman MJ, Elisaf M, Tselepis AD. Tsimihodimos V, et al. Among authors: elisaf m. J Lipid Res. 2003 May;44(5):927-34. doi: 10.1194/jlr.M200452-JLR200. Epub 2003 Mar 1. J Lipid Res. 2003. PMID: 12611907 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

812 results

Search Page

Filters